Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 23;29(16):2173-81.
doi: 10.1097/QAD.0000000000000808.

Cancers attributable to infections among adults with HIV in the United States

Affiliations

Cancers attributable to infections among adults with HIV in the United States

Catherine de Martel et al. AIDS. .

Abstract

Objective: HIV-infected people are at increased risk of cancers of infectious origin. We estimated the burden of cancer attributable to infections among HIV-infected people in the United States in 2008.

Design: Incidence rates for cancer sites associated with infections were estimated from record linkage between HIV/AIDS registries and cancer registries.

Methods: Rates were applied to estimates of the population living with diagnosed HIV in the United States in 2008 to obtain the number of incident cancer cases. Site-specific attributable fractions and corresponding 95% confidence intervals (CIs) were estimated from infection prevalence among cancer cases. Infection prevalence data were derived from literature review of case series.

Results: Of an estimated 6200 incident cancer cases (95% CI 6000-6500), 2500 (95% CI 2400-2700) were attributable to infection (attributable fraction = 40%, 95% CI 39-42). The most important infections were Kaposi sarcoma herpes virus, Epstein-Barr virus, and human papillomavirus, which together were responsible for 2200 new cancer cases (95% CI 2100-2400), mainly Kaposi sarcoma, lymphomas, and ano-genital cancers. The attributable fraction in HIV-infected people was highest in the age group 20-29 years (69%, 95% CI 65-72). MSM were the HIV transmission group with the highest attributable fraction (48%, 95% CI 46-50), due to the high incidence of both Kaposi sarcoma and anal cancer.

Conclusion: The very high fraction of cancer attributable to infection in HIV-infected people points to special opportunities to prevent these cancers, that is, avoidance, detection, and early treatment of cancer-associated infections, and universal early detection and uninterrupted treatment of HIV infection to avoid immunosuppression.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1. Cancer attributable to infection in the general population and HIV-infected people in the USA in 2008
Abbreviations: AF attributable fraction; KSHV Kaposi sarcoma herpes virus; EBV Epstein-Barr virus; HPV human papillomavirus; HBV hepatitis B virus; HCV hepatitis C virus; H. pylori Helicobacter pylori
Figure 2
Figure 2. Estimated cancer incidence among HIV-infected people in the USA in 2008 by age
Abbreviations: KSHV Kaposi sarcoma herpes virus; EBV Epstein-Barr virus; HPV human papillomavirus; HBV hepatitis B virus; HCV hepatitis C virus; H. pylori Helicobacter pylori

Similar articles

Cited by

References

    1. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100B : A Review of Human Carcinogens: Biological Agents. Lyon: International Agency for Research on Cancer; 2012.
    1. Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. Aids. 2008;22:2135–2141. - PubMed
    1. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577–586. - PubMed
    1. Sullivan SG, Hirsch HH, Franceschi S, Steffen I, Amari EB, Mueller NJ, et al. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. Aids. 2010;24:2245–2252. - PubMed
    1. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–432. - PubMed

Publication types